查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1318762

局部给药市场：按产品、给药途径和最终用户 - 2023-2030 年全球预测

Topical Drug Delivery Market by Product, Rout to Administration, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2023 年，全球局部给药市场将大幅成长，达到 1,149.6 亿美元，年复合成长率为 6.83%，预计到 2030 年将达到惊人的 1,828.5 亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球局部给药市场至关重要。透过检查业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.局部给药的全球市场规模和预测是多少？

2.在预测期内，COVID-19对全球局部给药市场的阻碍因素与影响有哪些？

3. 在预测期内，全球局部给药市场需要投资局部产品/细分市场/应用/领域？

4.全球局部给药市场的竞争策略为何？

5. 全球局部给药市场的技术趋势和法律规范是什么？

6.全球局部给药市场主要供应商的市占率为何？

7. 哪些型态和策略性措施被认为适合进入全球局部给药市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 皮肤病、罹患率率高，烧伤发生率高
      • 偏好经皮
      • 医疗自我管理和家庭护理的需要
    • 抑制因素
      • 更喜欢替代的药物传输模式
    • 机会
      • 为药物输送进步提供资金和投资
      • 开发改进的标靶治疗药物
    • 任务
      • 与皮肤刺激和渗透性相关的技术障碍
      • 药品故障和产品召回
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章局部给药市场：副产品

  • 液体配方
    • 解决方案
    • 暂停
  • 半固态製剂
    • 奶油
    • 凝胶
    • 洗剂
    • 软膏
    • 贴上
  • 固态製剂
    • 粉末
    • 塞剂
  • 经皮吸收产品
    • 经皮吸收贴片
    • 经皮半固体

第7章局部给药市场（依经理途径划分）

  • 经皮经皮
  • 鼻腔给药
  • 滴眼剂药物输送
  • 直肠给药
  • 阴道内给药

第8章局部给药市场：依最终使用者分类

  • 烧伤中心
  • 家庭护理设置
  • 医院和诊所

第9章美洲局部给药市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太本地局部市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第11章欧洲、中东和非洲局部给药市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第12章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业

第13章上市公司名单

第14章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-4316E4E8910D

The Global Topical Drug Delivery Market is forecasted to grow significantly, with a projected USD 114.96 billion in 2023 at a CAGR of 6.83% and expected to reach a staggering USD 182.85 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Topical Drug Delivery Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Topical Drug Delivery Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Liquid Formulations, Semi-Solid Formulations, Solid Formulations, and Transdermal Products. The Liquid Formulations is further studied across Solutions and Suspensions. The Semi-Solid Formulations is further studied across Creams, Gels, Lotions, Ointments, and Pastes. The Solid Formulations is further studied across Powders and Suppositories. The Transdermal Products is further studied across Transdermal Patches and Transdermal Semi-Solids. The Solid Formulations is projected to witness significant market share during forecast period.

Based on Rout to Administration, market is studied across Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, and Vaginal Drug Delivery. The Nasal Drug Delivery is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Burn Centers, Home Care Settings, and Hospitals & Clinics. The Burn Centers is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Topical Drug Delivery Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Topical Drug Delivery Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Topical Drug Delivery Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Topical Drug Delivery Market?

4. What is the competitive strategic window for opportunities in the Global Topical Drug Delivery Market?

5. What are the technology trends and regulatory frameworks in the Global Topical Drug Delivery Market?

6. What is the market share of the leading vendors in the Global Topical Drug Delivery Market?

7. What modes and strategic moves are considered suitable for entering the Global Topical Drug Delivery Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Topical Drug Delivery Market, by Product, 2022 vs 2030
  • 4.3. Topical Drug Delivery Market, by Rout to Administration, 2022 vs 2030
  • 4.4. Topical Drug Delivery Market, by End-User, 2022 vs 2030
  • 4.5. Topical Drug Delivery Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High prevalence of skin and eye diseases and incidence of burn injuries
      • 5.1.1.2. Preference for transdermal drug delivery
      • 5.1.1.3. Need for medical self-administration and home care
    • 5.1.2. Restraints
      • 5.1.2.1. Preference for alternative modes of drug delivery
    • 5.1.3. Opportunities
      • 5.1.3.1. Funding and investments for drug delivery advancements
      • 5.1.3.2. Development of improved targeted delivery of therapeutics
    • 5.1.4. Challenges
      • 5.1.4.1. Technical barriers related to skin irritation and permeability
      • 5.1.4.2. Drug failures and product recalls
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Topical Drug Delivery Market, by Product

  • 6.1. Introduction
  • 6.2. Liquid Formulations
    • 6.2.1. Solutions
    • 6.2.2. Suspensions
  • 6.3. Semi-Solid Formulations
    • 6.3.1. Creams
    • 6.3.2. Gels
    • 6.3.3. Lotions
    • 6.3.4. Ointments
    • 6.3.5. Pastes
  • 6.4. Solid Formulations
    • 6.4.1. Powders
    • 6.4.2. Suppositories
  • 6.5. Transdermal Products
    • 6.5.1. Transdermal Patches
    • 6.5.2. Transdermal Semi-Solids

7. Topical Drug Delivery Market, by Rout to Administration

  • 7.1. Introduction
  • 7.2. Dermal Drug Delivery
  • 7.3. Nasal Drug Delivery
  • 7.4. Ophthalmic Drug Delivery
  • 7.5. Rectal Drug Delivery
  • 7.6. Vaginal Drug Delivery

8. Topical Drug Delivery Market, by End-User

  • 8.1. Introduction
  • 8.2. Burn Centers
  • 8.3. Home Care Settings
  • 8.4. Hospitals & Clinics

9. Americas Topical Drug Delivery Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Topical Drug Delivery Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Topical Drug Delivery Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. TOPICAL DRUG DELIVERY MARKET RESEARCH PROCESS
  • FIGURE 2. TOPICAL DRUG DELIVERY MARKET SIZE, 2022 VS 2030
  • FIGURE 3. TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2022 VS 2030 (%)
  • FIGURE 6. TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 7. TOPICAL DRUG DELIVERY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. TOPICAL DRUG DELIVERY MARKET DYNAMICS
  • FIGURE 9. TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. TOPICAL DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. TOPICAL DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. TOPICAL DRUG DELIVERY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 6. TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. TOPICAL DRUG DELIVERY MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 10. TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. TOPICAL DRUG DELIVERY MARKET SIZE, BY LOTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. TOPICAL DRUG DELIVERY MARKET SIZE, BY PASTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 17. TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. TOPICAL DRUG DELIVERY MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. TOPICAL DRUG DELIVERY MARKET SIZE, BY SUPPOSITORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 21. TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL SEMI-SOLIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 25. TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. TOPICAL DRUG DELIVERY MARKET SIZE, BY NASAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. TOPICAL DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. TOPICAL DRUG DELIVERY MARKET SIZE, BY RECTAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. TOPICAL DRUG DELIVERY MARKET SIZE, BY VAGINAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. TOPICAL DRUG DELIVERY MARKET SIZE, BY BURN CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. TOPICAL DRUG DELIVERY MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 283. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 290. SWEDEN TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 297. SWITZERLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 304. TURKEY TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 311. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 325. TOPICAL DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 326. TOPICAL DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 327. TOPICAL DRUG DELIVERY MARKET LICENSE & PRICING